GC
STJ

Guggenheim Capital’s St Jude Medical STJ Stock Holding History

Guggenheim Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-465,784
Closed -$37.4M – 3007
2016
Q4 		$37.4M Buy
465,784
+31,599
+7% +$2.51M 0.11% 397
2016
Q3 		$34.6M Sell
434,185
-44,945
-9% -$3.63M 0.11% 354
2016
Q2 		$37.4M Sell
479,130
-109,861
-19% -$7.83M 0.12% 299
2016
Q1 		$32.4M Sell
588,991
-16,927
-3% -$922K 0.1% 350
2015
Q4 		$37.4M Buy
605,918
+91,244
+18% +$5.75M 0.11% 313
2015
Q3 		$32.5M Sell
514,674
-63,913
-11% -$4.56M 0.1% 348
2015
Q2 		$42.3M Sell
578,587
-59,421
-9% -$4.29M 0.1% 333
2015
Q1 		$41.7M Buy
638,008
+108,831
+21% +$7.24M 0.1% 355
2014
Q4 		$34.4M Sell
529,177
-120,686
-19% -$7.77M 0.09% 432
2014
Q3 		$39.1M Buy
649,863
+100,709
+18% +$6.58M 0.09% 326
2014
Q2 		$38M Buy
549,154
+46,169
+9% +$2.99M 0.1% 328
2014
Q1 		$32.9M Buy
502,985
+70,568
+16% +$4.59M 0.09% 330
2013
Q4 		$26.8M Buy
432,417
+91,677
+27% +$5.31M 0.08% 398
2013
Q3 		$18.3M Buy
340,740
+8,696
+3% +$448K 0.07% 513
2013
Q2 		$15.2M Buy
+332,044
New +$14.4M 0.06% 507

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Guggenheim Capital's STJ Position: Q1 2017 in Review

Guggenheim Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 465,784 shares — an estimated $37.4M sold.

Guggenheim Capital first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $42.3M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Guggenheim Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Guggenheim Capital sold 465,784 St Jude Medical shares in Q1 2017, an estimated $37.4M.
  • Guggenheim Capital first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Guggenheim Capital's St Jude Medical position peaked at $42.3M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Guggenheim Capital's 13F filing for Q1 2017, filed 15 May 2017.